O

OptiNose

D
OPTN
USD
0.0893
(12.7517%)
Market Closed
8,436.00
حجم التداول
-0.22
الربح لكل سهم
-
العائد الربحي
-2.322353
P/E
119,053,369.97
حجم السوق
اليوم
12.7517%
1 اسبوع
14.269%
1 شهر
13.123%
6 اشهر
-22.588%
12 اشهر
-34.744%
بداية السنة
-38.791%
كل الوقت
0%

Title:
OptiNose

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
هل تحتاج مساعدة او لديك استفسار؟